Apellis Pharmaceuticals Inc (APLS)
27.73
+0.24
(+0.87%)
USD |
NASDAQ |
Nov 21, 16:00
27.73
0.00 (0.00%)
After-Hours: 16:47
Apellis Pharmaceuticals Price to Book Value: 14.55 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 14.42 |
| November 19, 2024 | 15.21 |
| November 18, 2024 | 13.73 |
| November 15, 2024 | 13.78 |
| November 14, 2024 | 14.72 |
| November 13, 2024 | 14.82 |
| November 12, 2024 | 15.35 |
| November 11, 2024 | 15.52 |
| November 08, 2024 | 15.73 |
| November 07, 2024 | 15.08 |
| November 06, 2024 | 15.12 |
| November 05, 2024 | 14.73 |
| November 04, 2024 | 14.98 |
| November 01, 2024 | 14.68 |
| October 31, 2024 | 14.30 |
| October 30, 2024 | 14.54 |
| October 29, 2024 | 14.38 |
| October 28, 2024 | 14.07 |
| October 25, 2024 | 13.73 |
| October 24, 2024 | 14.20 |
| October 23, 2024 | 13.89 |
| October 22, 2024 | 14.21 |
| October 21, 2024 | 13.84 |
| October 18, 2024 | 14.41 |
| October 17, 2024 | 14.37 |
| Date | Value |
|---|---|
| October 16, 2024 | 14.39 |
| October 15, 2024 | 14.39 |
| October 14, 2024 | 14.10 |
| October 11, 2024 | 13.97 |
| October 10, 2024 | 13.73 |
| October 09, 2024 | 13.85 |
| October 08, 2024 | 14.11 |
| October 07, 2024 | 14.13 |
| October 04, 2024 | 14.16 |
| October 03, 2024 | 14.45 |
| October 02, 2024 | 14.66 |
| October 01, 2024 | 14.28 |
| September 30, 2024 | 14.85 |
| September 27, 2024 | 13.58 |
| September 26, 2024 | 13.75 |
| September 25, 2024 | 14.09 |
| September 24, 2024 | 14.17 |
| September 23, 2024 | 15.07 |
| September 20, 2024 | 14.98 |
| September 19, 2024 | 16.92 |
| September 18, 2024 | 16.41 |
| September 17, 2024 | 16.37 |
| September 16, 2024 | 16.73 |
| September 13, 2024 | 17.33 |
| September 12, 2024 | 16.94 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
7.220
Minimum
Apr 01 2020
101.13
Maximum
Jun 14 2021
27.05
Average
20.48
Median
Jan 12 2021
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.233 |
| Ionis Pharmaceuticals Inc | 8.091 |
| EyePoint Pharmaceuticals Inc | 2.604 |
| Cassava Sciences Inc | 9.294 |
| Macrogenics Inc | 1.675 |
Price to Book Value Related Metrics
| PS Ratio | 4.772 |
| Price | 27.73 |
| Earnings Yield | -7.32% |
| Market Cap | 3.449B |